Top Gainers Technical Data -- Research on BioScrip, Medivation, Array BioPharma, and Doral Financial
PR Newswire - Mon May 12, 7:17AM CDT
The US markets saw a positive sentiment on Friday, May 09, 2014, with the NASDAQ Composite closing at 4,071.87, up 0.50%, the Dow Jones Industrial Average ending the session at 16,583.34, up 0.20% and the S&P 500 edging 0.15% higher to finish the trading session at 1,878.48. The session saw a positive impact from Consumer Discretionary, Health Care and Consumer Staples sectors along with a drag from Financials, Energy and Utilities sectors. A number of stocks saw large movements, including BioScrip Inc. (NASDAQ: BIOS), Medivation Inc. (NASDAQ: MDVN), Array BioPharma Inc. (NASDAQ: ARRY) and Doral Financial Corporation (NYSE: DRL). Free technical research on BIOS, MDVN, ARRY and DRL can be downloaded upon signing up at:
Nasdaq stocks posting largest percentage increases
AP - Fri May 09, 5:04PM CDT
NEW YORK (AP) — A look at the 10 biggest percentage gainers on Nasdaq at the close of trading:
Why BioScrip, Tuesday Morning, and Polypore Are Today's 3 Best Stocks
Sean Williams, The Motley Fool - Motley Fool - Fri May 09, 4:15PM CDT
On Friday, Investors once again turned their attention to the mixed earnings landscape and pushed the broad-based S&P 500 from negative territory where it spent much of the day, to a slightly higher finish. Wholesale inventories rose 1.1% for...
Why BioScrip (BIOS) Stock Is Surging Today
at The Street - Fri May 09, 2:21PM CDT
BioScrip (BIOS) surged Friday after the pharmaceutical solutions company reported mixed first-quarter results and issued guidance that surpassed analysts' expectations.
Loss Wider than Ests, Poor Margins at BioScrip; Shares Sink - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri May 09, 11:50AM CDT
BioScrip, Inc. (BIOS) recently declared its first-quarter 2014 results.
BioScrip Down 11.3% Since SmarTrend Downtrend Call (BIOS)
Comtex SmarTrend(R) - Fri May 09, 9:24AM CDT
SmarTrend identified a Downtrend for BioScrip (NASDAQ:BIOS) on March 3rd, 2014 at $7.10. In approximately 2 months, BioScrip has returned 11.35% as of today's recent price of $6.29.
BioScrip Reports First Quarter 2014 Financial Results
PR Newswire - Thu May 08, 8:58PM CDT
BioScrip, Inc. (NASDAQ: BIOS) today announced 2014 first quarter financial results. First quarter revenue from continuing operations was $239.6 million and the net loss from continuing operations was $25.4 million, or $0.37 per basic and diluted share. Non-GAAP adjusted loss from continuing operations per basic and diluted share was $0.13.
Friday's Big Swing Trades: NiSource, PolyOne, Republic Airways
at The Street - Fri May 02, 11:32AM CDT
The technicals and charts are suggesting NiSource, PolyOne, and Republic Airways as today's swing trades.
3 Under-$10 Stocks Triggering Breakouts
at The Street - Fri May 02, 7:11AM CDT
These stocks under $10 are within range of triggering breakout trades.
BioScrip To Host First Quarter 2014 Earnings Call
PR Newswire - Thu Apr 24, 3:30PM CDT
BioScrip®, Inc. (NASDAQ: BIOS) announced today that the Company will release its 2014 first quarter financial results on Thursday, May 8, 2014, after the market closes.
Zacks Rank #5 Additions for Monday - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Apr 21, 8:30AM CDT
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List for Monday
Zacks Rank #5 Additions for Tuesday - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Apr 15, 8:30AM CDT
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List for Tuesday
Zacks Rank #5 Additions for Wednesday - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Apr 09, 8:30AM CDT
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List for Wednesday
Top Gainers Technical Data -- Research on BioScrip, E-House China Holdings, MagneGas, and Idera Pharma
PR Newswire - Wed Apr 09, 7:47AM CDT
On Tuesday, April 08, 2014, the US markets saw a positive sentiment, with the NASDAQ Composite closing at 4,112.99, up 0.81%, the Dow Jones Industrial Average ending the session at 16,256.14, up 0.06%, and the S&P 500 edging 0.38% higher to finish the trading session at 1,851.96. The session saw a positive impact from Consumer Discretionary, Energy and Utilities sectors along with a drag from Health Care, Industrials and Telecommunication Services sectors. A number of stocks saw large movements, including BioScrip Inc. (NASDAQ: BIOS), E-House China Holdings Ltd (NYSE: EJ), MagneGas Corp. (NASDAQ: MNGA) and Idera Pharmaceuticals Inc. (NASDAQ: IDRA). Free technical research on BIOS, EJ, MNGA and IDRA can be downloaded upon signing up at:
Product Launches, Acquisitions, Closed Offerings, Divestitures, and Financial Results - Analyst Notes on Dr. Reddy's, ICON, Endocyte, BioScrip, and DepoMed
PR Newswire - Mon Apr 07, 7:00AM CDT
Today, Analysts Review released its analysts' notes regarding Dr. Reddy's Laboratories Ltd. (NYSE: RDY), ICON plc (NASDAQ: ICLR), Endocyte, Inc. (NASDAQ: ECYT), BioScrip Inc. (NASDAQ: BIOS), and DepoMed Inc. (NASDAQ: DEPO). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.AnalystsReview.com/register
4 Under-$10 Stocks to Trade for Breakouts
at The Street - Fri Apr 04, 7:50AM CDT
These under-$10 stocks are within range of triggering breakout trades.
BioScrip Completes Sale of Home Health Services Business to LHC Group
PR Newswire - Tue Apr 01, 6:06AM CDT
BioScrip®, Inc. (NASDAQ: BIOS) today announced that it has completed the previously announced sale of substantially all of its Home Health business, known as Deaconess HomeCare, to LHC Group, Inc. (NASDAQ: LHCG). The transaction represents a total deal value of approximately $60 million. BioScrip intends to use the net proceeds from the sale to pay down a portion of its outstanding debt.
LHC Group Completes Acquisition of Deaconess HomeCare
GlobeNewswire - Tue Apr 01, 6:03AM CDT
LHC Group Inc. (Nasdaq:LHCG), a national provider of home health, hospice and comprehensive post-acute healthcare services, announced today that it has completed the previously announced transaction with BioScrip(R), Inc. (Nasdaq:BIOS) to purchase two of its operating subsidiaries, doing business as Deaconess HomeCare and Elk Valley Health Services, for $59.5 million. The transaction adds 32 agencies in four states, increasing LHC Group's geographical footprint to 340 post-acute care agencies across 26 states, and is anticipated to be accretive to LHC Group's 2014 earnings by between $0.05 and $0.10 per diluted share.